Neoadjuvant transcatheter arterial chemoembolization does not provide survival benefit compared to curative therapy alone in single hepatocellular carcinoma

Neoadjuvant transcatheter arterial chemoembolization does not provide survival benefit compared to curative therapy alone in single hepatocellular carcinoma

The role of transcatheter arterial chemoembolization (TACE) prior to curative therapy is still unclear. The aim of our study was to elucidate the survival of single hepatocellular carcinoma (HCC) and also to clarify whether TACE plus sequential curative therapy provides benefits in single HCC. A tot...

Full description

Bibliographic Details
Main Authors: Ming-Lun Yeh, Ching-I Huang, Chung-Feng Huang, Ming-Yen Hsieh, Jee-Fu Huang, Chia-Yen Dai, Zu-Yau Lin, Shinn-Cherng Chen, Ming-Lung Yu, Wan-Long Chuang
Format: Article
Language:English
Published: Wiley 2015-02-01
Series:Kaohsiung Journal of Medical Sciences
Subjects:
Hepatocellular carcinoma
Neoadjuvant
Recurrence
Survival
Transcatheter arterial chemoembolization
Online Access:http://www.sciencedirect.com/science/article/pii/S1607551X14002265

Internet

http://www.sciencedirect.com/science/article/pii/S1607551X14002265

Similar Items